The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 08, 2020
Filed:
Jun. 07, 2019
Applicant:
Forsight Vision4, Inc., Menlo Park, CA (US);
Inventors:
Judit Horvath, Menlo Park, CA (US);
Irina Astafieva, Menlo Park, CA (US);
Signe Erickson, Menlo Park, CA (US);
Kathleen Cogan Farinas, Menlo Park, CA (US);
Assignee:
ForSight Vision4, Inc., Menlo Park, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 47/69 (2017.01); A61K 47/20 (2006.01); A61K 47/40 (2006.01); A61K 9/19 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 47/32 (2006.01); A61M 5/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61K 47/32 (2013.01); A61K 47/40 (2013.01); A61K 47/6951 (2017.08); A61M 5/14 (2013.01);
Abstract
The present disclosure relates to stable formulations of receptor tyrosine kinase inhibitors (TKI), e.g., pazopanib; methods of preparation thereof; and use of the disclosed formulations in sustained delivery of the active agent to a target site. The disclosure further relates to methods of converting one polymorphic Form of a TKI to another polymorphic Form and/or an amorphous form.